Cargando…

TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer

BACKGROUND: TMPRSS2:ERG gene aberration may be a novel marker that improves risk stratification of prostate cancer before definitive cancer therapy, but studies have been inconclusive. METHODS: The study cohort consisted of 202 operable prostate cancer Slovenian patients who underwent laparoscopic r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krstanoski, Zoran, Vokac, Nadja Kokalj, Zagorac, Andreja, Pospihalj, Boris, Munda, Miha, Dzeroski, Saso, Golouh, Rastko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932765/ https://www.ncbi.nlm.nih.gov/pubmed/27377958 http://dx.doi.org/10.1186/s12894-016-0160-8

Ejemplares similares

A mosaic form of microphthalmia with linear skin defects
por: Prepeluh, Nina, et al.
Publicado: (2018)

An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas
por: Kokalj Vokač, Nadja, et al.
Publicado: (2014)

Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test
por: Kavcic, Niko, et al.
Publicado: (2022)

Submicroscopic interstitial deletion of chromosome 11q22.3 in a girl with mild mental retardation and facial dysmorphism: Case report
por: Krgovic, Danijela, et al.
Publicado: (2011)

Rare structural variants in the DOCK8 gene identified in a cohort of 439 patients with neurodevelopmental disorders
por: Krgovic, Danijela, et al.
Publicado: (2018)

Identification of genomic copy number variations associated with specific clinical features of head and neck cancer
por: Zagradišnik, Boris, et al.
Publicado: (2018)

A coalescence of two syndromes in a girl with terminal deletion and inverted duplication of chromosome 5
por: Krgovic, Danijela, et al.
Publicado: (2014)

CNVs and Chromosomal Aneuploidy in Patients With Early-Onset Schizophrenia and Bipolar Disorder: Genotype-Phenotype Associations
por: Gregoric Kumperscak, Hojka, et al.
Publicado: (2021)

5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
por: Zammarchi, Francesca, et al.
Publicado: (2013)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2021)

Significance of the TMPRSS2:ERG gene fusion in prostate cancer
por: Wang, Zhu, et al.
Publicado: (2017)

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009)

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)

TMPRSS2-ERG fusion promotes prostate cancer metastases in bone
por: Deplus, Rachel, et al.
Publicado: (2016)

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
por: Krumbholz, Manuela, et al.
Publicado: (2019)

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort
por: Esgueva, Raquel, et al.
Publicado: (2010)

Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2023)

Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression
por: Yin, Lihong, et al.
Publicado: (2011)

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
por: Salagierski, Maciej, et al.
Publicado: (2010)

TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells
por: Zhou, Feng, et al.
Publicado: (2019)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
por: Giunchi, Francesca, et al.
Publicado: (2020)

Machine learning-ready remote sensing data for Maya archaeology
por: Kokalj, Žiga, et al.
Publicado: (2023)

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
por: Hägglöf, Christina, et al.
Publicado: (2014)

Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
por: Hansen, Ailin Falkmo, et al.
Publicado: (2016)

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020)

Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway
por: Afshari, Afsoon, et al.
Publicado: (2021)

A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma
por: Zhou, Emily, et al.
Publicado: (2020)

TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence
por: Fang, Lei, et al.
Publicado: (2022)

Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
por: Li, Chengxun, et al.
Publicado: (2023)

PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations
por: Pascal, Laura E, et al.
Publicado: (2016)

Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG
por: Roberts, Justin M., et al.
Publicado: (2017)

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer
por: Urbinati, Giorgia, et al.
Publicado: (2015)

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
por: Semaan, Louie, et al.
Publicado: (2019)

Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer
por: Xu, Zhenyu, et al.
Publicado: (2018)

Hydrolysis Profiles of Formalin Fixed Paraffin-Embedded Tumors Based on IOD (Integrated Optical Density) and Nuclear Texture Feature Measurements
por: Fležar, Margareta, et al.
Publicado: (1999)

Status of TMPRSS2–ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism
por: Bhanushali, Aparna, et al.
Publicado: (2018)

A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants
por: Lu, Qing, et al.
Publicado: (2008)

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
por: Brase, Jan C, et al.
Publicado: (2011)

Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide
por: Urbinati, Giorgia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s65tq95uo5b3rs4mii6ng5f8u1